De Backer Marianne — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

De Backer Marianne has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $947K.

Profile

Marianne De Backer is a prominent executive in the biotechnology industry, currently serving as the Chief Executive Officer of Vir Biotechnology, Inc. She has a strong background in pharmaceutical and biotechnology sectors, with extensive experience in leadership roles. De Backer has been recognized for her contributions to advancing innovative therapies and has played a significant role in the strategic direction of her company.

Board memberships

• Vir Biotechnology, Inc.

Awards & honors

• Leadership in biotechnology innovation
• Strategic growth of Vir Biotechnology, Inc.

Recent Transactions

Companies — Last 90 Days

• Vir Biotechnology, Inc. (VIR) — 1 filings, last 2026-04-30

Frequently Asked Questions

Who is De Backer Marianne?

Marianne De Backer is a prominent executive in the biotechnology industry, currently serving as the Chief Executive Officer of Vir Biotechnology, Inc. She has a strong background in pharmaceutical and biotechnology sectors, with extensive experience in leadership roles. De Backer has been recognized for her contributions to advancing innovative therapies and has played a signif…

How many SEC Form 4 filings has De Backer Marianne submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has De Backer Marianne been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 3 open-market sales ($947K) across all tracked filings.

Where can I see all of De Backer Marianne's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week